Synthetic magnetic resonance imaging (SyMRI) enables to reformat various images by adjusting the MR parameters.
Purpose
To investigate whether customization of the repetition time (TR), echo time (TE), and inversion time (TI) in SyMRI could improve the visualization of subthalamic nucleus (STN).
Material and Methods
We examined five healthy volunteers using both coronal SyMRI and quantitative susceptibility mapping (QSM), seven patients with Parkinson's disease (PD) using coronal SyMRI, and 15 patients with PD using coronal QSM. Two neuroradiologists reformatted SyMRI (optimized SyMRI) by adjusting TR, TE, and TI to achieve maximum tissue contrast between the STN and the adjacent brain parenchyma. The optimized MR parameters in the PD patients varied according to the individual. For regular SyMRI (T2-weighted imaging [T2WI] and STIR), optimized SyMRI, and QSM, qualitative visualization scores of the STN (STN score) were recorded. The contrast-to-noise ratio (CNR) of the STN was also measured.
Results
For the STN scores in both groups, the optimized SyMRI were significantly higher than the regular SyMRI (P < 0.05), and there were no significant differences between optimized SyMRI and QSM. For the CNR of differentiation of the STN from the substantia nigra, the optimized SyMRI was higher than the regular SyMRI (volunteer: T2WI P = 0.10 and STIR P = 0.26; PD patient: T2WI P = 0.43 and STIR P = 0.25), but the optimized SyMRI was lower than the QSM (volunteer: P = 0.26; PD patient: P = 0.03).
Conclusions
On SyMRI, optimization of MR parameters (TR, TE, and TI) on an individual basis may be useful to increase the conspicuity of the STN.
KumarRLozanoAMKimYJ, et al.Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology1998;51:850–855.
2.
LimousinPKrackPPollakP, et al.Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med1998;339:1105–1111.
3.
PaekSHYunJYSongSW, et al.The clinical impact of precise electrode positioning in STN DBS on three-year outcomes. J Neurol Sci2013;327:25–31.
4.
OkunMSTagliatiMPourfarM, et al.Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol2005;62:1250–1255.
5.
MasseyLMirandaMZrinzoL, et al.High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage2012;59:2035–2044.
6.
KitajimaMKorogiYKakedaS, et al.Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0 T. Neuroradiology2008;50:675.
7.
AboschAYacoubEUgurbilK, et al.An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla. Neurosurgery2010;67:1745–1756.
8.
ChoZ-HMinH-KOhS-H, et al.Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging. J Neurosurg2010;113:639–647.
9.
StarrPAChristineCWTheodosopoulosPV, et al.Implantation of deep brain stimulators into subthalmic nucleus: technical approach and magnetic imaging—verified electrode locations. J Neurosurg2002;97:370–387.
10.
ZonenshaynMRezaiARMogilnerAY, et al. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery2000;47:282–292; discussion 292–284.
11.
LiuTEskreis-WinklerSSchweitzerAD, et al.Improved subthalamic nucleus depiction with quantitative susceptibility mapping. Radiology2013;269:216–223.
12.
LiJChangSLiuT, et al.Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn Reson Med2012;68:1563–1569.
13.
RiedererSJSuddarthSABobmanSA, et al.Automated MR image synthesis: feasibility studies. Radiology1984;153:203–206.
14.
WarntjesMJKihlbergJEngvallJ. Rapid T1 quantification based on 3D phase sensitive inversion recovery. BMC Med Imaging2010;10:19.
15.
WarntjesJBLeinhardODWestJ, et al.Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med2008;60:320–329.
16.
MearaSJBarkerGJ. Evolution of the longitudinal magnetization for pulse sequences using a fast spin-echo readout: application to fluid-attenuated inversion-recovery and double inversion-recovery sequences. Magn Reson Med2005;54:241–245.
17.
LeeSHLeeYHHahnS, et al.Optimization of T2-weighted imaging for shoulder magnetic resonance arthrography by synthetic magnetic resonance imaging. Acta Radiol2018;59:959–965.
18.
WarntjesJBEngströmMTisellA, et al.Brain characterization using normalized quantitative magnetic resonance imaging. PloS one2013;8:e70864.
19.
WarntjesJBDahlqvistOLundbergP. Novel method for rapid, simultaneous T1, T2*, and proton density quantification. Magn Reson Med2007;57:528–537.
20.
TaokaTHirabayashiHNakagawaH, et al.“Sukeroku sign” and “dent internal-capsule sign”—identification guide for targeting the subthalamic nucleus for placement of deep brain stimulation electrodes. Neuroradiology2009;51:11.
21.
de RochefortLLiuTKresslerB, et al.Quantitative susceptibility map reconstruction from MR phase data using Bayesian regularization: validation and application to brain imaging. Magn Reson Med2010;63:194–206.
22.
SchweserFRobinsonSDde RochefortL, et al.An illustrated comparison of processing methods for phase MRI and QSM: removal of background field contributions from sources outside the region of interestNMR Biomed2017;30:e3604.
23.
LiuTSurapaneniKLouM, et al.Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology2012;262:269–278.
24.
LangkammerCLiuTKhalilM, et al.Quantitative susceptibility mapping in multiple sclerosis. Radiology2013;267:551–559.
25.
LiuTKhalidovIde RochefortL, et al.A novel background field removal method for MRI using projection onto dipole fields. NMR Biomed2011;24:1129–1136.
26.
LiuTLiuJde RochefortL, et al.Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magn Reson Med2011;66:777–783.
27.
SmithSM. Fast robust automated brain extraction. Hum Brain Mapp2002;17:143–155.
28.
WestHLeachJLJonesBV, et al.Clinical validation of synthetic brain MRI in children: initial experience. Neuroradiology2017;59:43–50.
29.
KraussWGunnarssonMNilssonM, et al.Conventional and synthetic MRI in multiple sclerosis: a comparative study. Eur Radiol2018;28:1692–1700.
30.
GranbergTUppmanMHashimF, et al.Clinical feasibility of synthetic MRI in multiple sclerosis: a diagnostic and volumetric validation study. AJNR Am J Neuroradiol2016;37:1023–1029.
31.
RyuKHChoiDSBaekHJ, et al.Clinical feasibility of 1-min ultrafast brain MRI compared with routine brain MRI using synthetic MRI: a single center pilot study. J Neurol2019;266:431–439.
32.
OikawaHSasakiMTamakawaY, et al.The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol2002;23:1747–1756.
33.
SaekiNKansakuKHiguchiY, et al.Demonstration of the postcommissural fibres of the fornix in short-inversion time inversion-recovery imaging on a high-field system. Neuroradiology2001;43:547–550.
34.
DexterDTCarayonAJavoy-AgidF, et al.Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain1991;114:1953–1975.
35.
GrahamJMPaleyMNGrünewaldRA, et al.Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain2000; 123: 2423–2431.
36.
KakedaSKorogiYYonedaT, et al.Parkinson's disease: diagnostic potential of high-resolution phase difference enhanced MR imaging at 3 T. Eur Radiol2013; 23: 1102–1111.
37.
MurakamiYKakedaSWatanabeK, et al.Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. AJNR Am J Neuroradiol2015; 36: 1102–1108. DOI: 10.3174/ajnr.A4260.
38.
JinLWangJZhaoL, et al.Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease. Brain2011;134:50–58.
39.
WeiHZhangCWangT, et al.Precise targeting of the globus pallidus internus with quantitative susceptibility mapping for deep brain stimulation surgery. J Neurosurg2019;133:1–7.
40.
IdeSKakedaSUedaI, et al.Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM). Eur Radiol2015; 25: 710–718. DOI: 10.1007/s00330-014-3472-7.
41.
FujitaSHagiwaraAHoriM, et al.3D quantitative synthetic MRI-derived cortical thickness and subcortical brain volumes: scan-rescan repeatability and comparison with conventional T1 -weighted images. J Magn Reson Imaging2019;50:1834–1842.
42.
FujitaSHagiwaraAOtsukaY, et al.Deep learning approach for generating MRA images from 3D quantitative synthetic MRI without additional scans. Invest Radiol2020;55:249–256.
